Status:
COMPLETED
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Sickle Cell Anemia
Sickle Cell Thalassemia
Eligibility:
All Genders
Brief Summary
This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.
Detailed Description
The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment. The study cohort included 60 SCA patients actually treated in the Pediatri...
Eligibility Criteria
Inclusion
- All patients admitted with fever as the only presenting symptom.
Exclusion
- Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00736060
Start Date
May 1 2008
End Date
November 1 2008
Last Update
August 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Hematology Unit - Ha'Emek Medical Center
Afula, Afula, Israel, 18101